Randomized, Double‐Blind, Placebo‐Controlled, Multiple‐Dose Studies to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing and Progressive Forms of Multiple Sclerosis
- Journal:
- Annals of Neurology
- Published:
- DOI:
- 10.1002/ana.27262
- Affiliations:
- 4
- Authors:
- 7
| Institutions | Authors | Share |
|---|---|---|
| AbbVie, United States of America (USA) | 0.57 | |
| UCSF Medical Center, United States of America (USA) | 0.14 | |
| The Ottawa Hospital (TOH), Canada | 0.14 | |
| UW Medicine, United States of America (USA) | 0.14 |